Gene Therapy Platform Market
完整報告名稱與涵蓋範圍
Gene Therapy Platform Market Size, Share & Trends Analysis Report, By Platform Type (Viral Vector Platforms, Non-Viral Vector Platforms), By Therapeutic Application, By Delivery Mode, By End Use, By Region, Forecasts, 2025-2034
報告摘要
With a 2024 valuation of USD 2.2 Bn, the global Gene Therapy Platform Market is expected to develop to USD 9.8 Bn by 2034, demonstrating a CAGR of 16.5% during the 2025–2034 forecast window.
Gene Therapy Platform covers reshaping how healthcare entities approach this space.
Growth is supported by a convergence of factors: rising awareness among end users, continuous product innovation, and the expanding emphasis on efficiency and sustainability within the healthcare sector.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region expected to deliver the strongest growth trajectory through the forecast period, supported by demographic shifts and policy support.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Applicationology and Scope
1.1. Research Applicationology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Gene Therapy Platform Market Snapshot
Chapter 4. Global Gene Therapy Platform Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2025-2034
4.8. Global Gene Therapy Platform Market Penetration & Growth Prospect Mapping (US$ Mn), 2024-2034
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2024)
4.10. Use/impact of AI on GENE THERAPY PLATFORM MARKET Industry Trends
Chapter 5. Gene Therapy Platform Market Segmentation 1: By Platform Type, Estimates & Trend Analysis
5.1. Market Share by Platform Type, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Platform Type:
5.2.1. Viral Vector Platforms
5.2.1.1. Adeno-associated Virus (AAV)
5.2.1.2. Lentivirus
5.2.1.3. Retrovirus
5.2.1.4. Adenovirus
5.2.1.5. Herpes Simplex Virus (HSV)
5.2.2. Non-Viral Vector Platforms
5.2.2.1. Lipid Nanoparticles (LNPs)
5.2.2.2. Electroporation & Microinjection Platforms
5.2.2.3. Polymer-based Delivery Systems
5.2.2.4. Naked DNA/RNA Delivery
5.2.3. Gene Editing Platforms
5.2.3.1. CRISPR-Cas Systems
5.2.3.2. TALENs
5.2.3.3. ZFNs
Chapter 6. Gene Therapy Platform Market Segmentation 2: By Delivery Mode, Estimates & Trend Analysis
6.1. Market Share by Delivery Mode, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Delivery Mode:
6.2.1. In Vivo Gene Therapy
6.2.2. Ex Vivo Gene Therapy
6.2.2.1. Autologous Cell-Based Gene Therapy
6.2.2.2. Allogeneic Cell-Based Gene Therapy
6.2.3. Others (In-situ Gene therapy)
Chapter 7. Gene Therapy Platform Market Segmentation 3: By Application, Estimates & Trend Analysis
7.1. Market Share by Application, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
7.2.1. Oncology
7.2.2. Rare Genetic Disorders
7.2.3. Cardiovascular Diseases
7.2.4. Neurological Disorders
7.2.5. Ophthalmic Diseases
7.2.6. Hematological Disorders (e.g., Hemophilia, Sickle Cell)
7.2.7. Musculoskeletal Disorders
7.2.8. Infectious Diseases (e.g., HIV, COVID-19 adjunct therapies)
Chapter 8. Gene Therapy Platform Market Segmentation 4: By End Use, Estimates & Trend Analysis
8.1. Market Share by End Use, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following End Use:
8.2.1. Pharmaceutical & Biotechnology Companies
8.2.2. Academic & Research Institutions
8.2.3. Contract Development & Manufacturing Organizations (CDMOs)
8.2.4. Hospitals & Gene Therapy Centers
Chapter 9. Gene Therapy Platform Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Gene Therapy Platform Market , Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America Gene Therapy Platform Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Gene Therapy Platform Market Revenue (US$ Million) Estimates and Forecasts by Platform Type, 2021-2034
9.2.3. North America Gene Therapy Platform Market Revenue (US$ Million) Estimates and Forecasts by Delivery Mode, 2021-2034
9.2.4. North America Gene Therapy Platform Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.2.5. North America Gene Therapy Platform Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2021-2034
9.3. Europe
9.3.1. Europe Gene Therapy Platform Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Gene Therapy Platform Market Revenue (US$ Million) Estimates and Forecasts by Platform Type, 2021-2034
9.3.3. Europe Gene Therapy Platform Market Revenue (US$ Million) Estimates and Forecasts by Delivery Mode, 2021-2034
9.3.4. Europe Gene Therapy Platform Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.3.5. Europe Gene Therapy Platform Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific Gene Therapy Platform Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. South Korea
9.4.1.5. Southeast Asia
9.4.1.6. Rest of Asia Pacific
9.4.2. Asia Pacific Gene Therapy Platform Market Revenue (US$ Million) Estimates and Forecasts by Platform Type, 2021-2034
9.4.3. Asia Pacific Gene Therapy Platform Market Revenue (US$ Million) Estimates and Forecasts by Delivery Mode, 2021-2034
9.4.4. Asia Pacific Gene Therapy Platform Market Revenue (US$ Million) Estimates and Forecasts By Application, 2021-2034
9.4.5. Asia Pacific Gene Therapy Platform Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2021-2034
9.5. Latin America
9.5.1. Latin America Gene Therapy Platform Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Argentina
9.5.1.4. Rest of Latin America
9.5.2. Latin America Gene Therapy Platform Market Revenue (US$ Million) Estimates and Forecasts by Platform Type, 2021-2034
9.5.3. Latin America Gene Therapy Platform Market Revenue (US$ Million) Estimates and Forecasts by Delivery Mode, 2021-2034
9.5.4. Latin America Gene Therapy Platform Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.5.5. Latin America Gene Therapy Platform Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Gene Therapy Platform Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. South Africa
9.6.1.3. Rest of Middle East and Africa
9.6.2. Middle East & Africa Gene Therapy Platform Market Revenue (US$ Million) Estimates and Forecasts by Platform Type, 2021-2034
9.6.3. Middle East & Africa Gene Therapy Platform Market Revenue (US$ Million) Estimates and Forecasts by Delivery Mode, 2021-2034
9.6.4. Middle East & Africa Gene Therapy Platform Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.6.5. Middle East & Africa Gene Therapy Platform Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Lonza
10.2.1.1. Business Overview
10.2.1.2. Key Product/Service
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. BioIT
10.2.3. Autolomous Ltd
10.2.4. Hypertrust Patient Data Care (Part of Accenture)
10.2.5. IBM
10.2.6. L7 Informatics, Inc.
10.2.7. TrakCel
10.2.8. IDBS
10.2.9. Novartis
10.2.10. SAP SE
10.2.11. DEEP GENOMICS
10.2.12. ElevateBio
10.2.13. Sarepta Therapeutics, Inc.
10.2.14. CRISPR Therapeutics
10.2.15. Precision BioSciences
10.2.16. AstraZeneca
10.2.17. Andelyn Biosciences
10.2.18. Renova Therapeutics
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們